| Announce Date | 10/22/2025 |
| EPS Normalized Actual | $6.85 (Beat by $0.65) |
| EPS GAAP Actual | $6.85 (Beat by $0.65) |
| Revenue Actual | $2.28762B |
| Revenue Surprise | Beat by $2287.62M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $5.895 |
| EPS GAAP Estimate | $5.895 |
| Revenue Estimate | $1.9637215B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2028 | 32.3 | 18.22 | 31.79293 | 32.78095 | 2 |
| Jun 2027 | 22.20462 | 26.51 | 21.31571 | 22.93285 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.67 | -0.54072 | 2.28762B | 10.09% | 289.7M |
| FQ2 2025 (Jun 2025) | 7.18 | 7.18 | 2.30414B | 11.54% | 2304.14M |
| FQ1 2025 (Mar 2025) | 5.02 | -0.97295 | 2.16698B | 10.59% | 152.63M |
| FQ4 2024 (Dec 2024) | 4.9 | 4.9 | 2.09981B | 12.66% | 2099.81M |
| FQ3 2024 (Sep 2024) | 5.39 | 5.39 | 2.05689B | 10.05% | 2056.89M |
| FQ2 2024 (Jun 2024) | 6.04 | 6.04 | 2.0383B | 16.45% | 2038.3M |
| FQ1 2024 (Mar 2024) | 5.17 | 5.17 | 1.93746B | 9.97% | 1937.46M |
| FQ4 2023 (Dec 2023) | 3.76 | 3.76 | 1.83393B | 10.06% | 1833.93M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
5.895
Consensus Revenue Estimates
1.9637215B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 9.91206 | -- | 9.72683 | 10.16817 | 4 |
| FQ4 2027 (Dec 2027) | 8.99842 | -- | 8.83027 | 9.23092 | 5 |
| FQ3 2027 (Sep 2027) | 8.60432 | -- | 8.44353 | 8.82664 | 3 |
| FQ1 2027 (Mar 2027) | 8.19363 | -- | 7.76318 | 8.62471 | 2 |
| FQ4 2026 (Dec 2026) | 7.7262 | -- | 7.32031 | 8.13269 | 2 |
| FQ3 2026 (Jul 2026) | 6.705 | 15.44 | 6.43259 | 6.90652 | 1 |
| FQ1 2026 (Mar 2026) | 6.29 | 20.19 | 5.89921 | 6.56696 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.68B | -- | 2.64B | 2.73B | 3 |
| FQ4 2027 (Dec 2027) | 2.59B | -- | 2.55B | 2.64B | 6 |
| FQ3 2027 (Sep 2027) | 2.57B | -- | 2.54B | 2.63B | 4 |
| FQ1 2027 (Mar 2027) | 2.44B | -- | 2.34B | 2.54B | 3 |
| FQ4 2026 (Dec 2026) | 2.43B | -- | 2.33B | 2.53B | 3 |
| FQ3 2026 (Jul 2026) | 2.08B | -9.99 | 2.01B | 2.13B | 2 |
| FQ1 2026 (Mar 2026) | 2.07B | -4.48 | 1.97B | 2.14B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 6.21072 | 5.67 | -0.54072 | -9.54% |
| FQ2 2025 (Jun 2025) | 7.18 | 7.18 | 100% | |
| FQ1 2025 (Mar 2025) | 5.99295 | 5.02 | -0.97295 | -19.38% |
| FQ4 2024 (Dec 2024) | 4.9 | 4.9 | 100% | |
| FQ3 2024 (Sep 2024) | 5.39 | 5.39 | 100% | |
| FQ2 2024 (Jun 2024) | 6.04 | 6.04 | 100% | |
| FQ1 2024 (Mar 2024) | 5.17 | 5.17 | 100% | |
| FQ4 2023 (Dec 2023) | 3.76 | 3.76 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2B | $2.29B | $289.7M | 12.66% |
| FQ2 2025 (Jun 2025) | $0B | $2.3B | $2304.14M | 100% |
| FQ1 2025 (Mar 2025) | $2.01B | $2.17B | $152.63M | 7.04% |
| FQ4 2024 (Dec 2024) | $0B | $2.1B | $2099.81M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.06B | $2056.89M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.04B | $2038.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.94B | $1937.46M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.83B | $1833.93M | 100% |